Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FWFDA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,166
Award facts
- Contract value 100% obligated
- $4,165.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,165.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 17, 2025, for the supply of 68 milligram Nexplanon implants, with an ultimate completion date of October 8, 2025. This delivery order was issued without set-aside designation and is being performed in Park Ridge, Illinois, where the awardee is headquartered. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected to fulfill this requirement through its existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion vehicle established to support comprehensive pharmaceutical supply needs for Department of Defense healthcare facilities.
As a specialized pharmaceutical distributor registered in SAM.gov since 2001, DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a robust portfolio of delivery orders covering prescription medications, biologics, and medical consumables. The Nexplanon implant delivery represents one of multiple contraceptive and specialty pharmaceutical products the company supplies to military health facilities nationwide. The firm's ability to compete effectively in federal procurement markets while maintaining consistent contract awards demonstrates its operational capacity and reliability in meeting Defense Logistics Agency pharmaceutical distribution requirements across diverse product categories and geographic locations.
Quick answers
Who was awarded contract SPE2DB25FWFDA?
SPE2DB25FWFDA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FWFDA worth?
The government has obligated $4,166 on SPE2DB25FWFDA.
Is contract SPE2DB25FWFDA an order under another contract?
Yes. SPE2DB25FWFDA is a delivery order under SPE2DB25D9320, an indefinite delivery contract.
Was contract SPE2DB25FWFDA competed?
The extent of competition for SPE2DB25FWFDA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award